TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

2005 • 5,086 citations

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

1989 • 3,308 citations

Delivering nanomedicine to solid tumors

2010 • 2,903 citations

Molecular regulation of vessel maturation

2003 • 2,446 citations

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

2011 • 2,231 citations

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

2011 • 1,483 citations

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

2011 • 1,418 citations

Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

2004 • 1,160 citations

Role of extracellular matrix assembly in interstitial transport in solid tumors.

2000 • 1,126 citations

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

2012 • 1,017 citations

Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis

2009 • 851 citations

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

2003 • 820 citations

Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

2012 • 770 citations

Delivery of molecular and cellular medicine to solid tumors

2012 • 766 citations

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

2011 • 642 citations

Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

2001 • 576 citations

Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies

2011 • 532 citations

Delivery of molecular and cellular medicine to solid tumors1PII of original article: S0169-409X(97)00027-6. The article was originally published in Advanced Drug Delivery Reviews 26 (1997) 71–90.1

2001 • 509 citations

Transforming growth factor-β in cancer and metastasis

2006 • 500 citations

Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

2002 • 490 citations

The next frontier of molecular medicine: Delivery of therapeutics

1998 • 408 citations

Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

2002 • 406 citations

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

2007 • 397 citations

Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector

2006 • 377 citations

Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

1999 • 362 citations

The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells

2006 • 238 citations

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

2003 • 231 citations

Evidence that Furin Is an Authentic Transforming Growth Factor-β1-Converting Enzyme

2001 • 230 citations

Evaluation of Anti-TGF-β2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery

2003 • 222 citations

Proprotein convertases: “Master switches” in the regulation of tumor growth and progression

2005 • 220 citations

An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments

2008 • 219 citations

TGF- Biology in Mammary Development and Breast Cancer

2010 • 214 citations

Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line

2006 • 176 citations

PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products

1995 • 175 citations

TGF Beta Inhibition for Cancer Therapy

2006 • 118 citations

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

2010 • 115 citations

Intraperitoneal Immunotherapy for Metastatic Ovarian Carcinoma: Resistance of Intratumoral Collagen to Antibody Penetration

2006 • 100 citations

Processing of Immunosuppressive Pro-TGF-β1,2 by Human Glioblastoma Cells Involves Cytoplasmic and Secreted Furin-Like Proteases

2001 • 96 citations

Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.

2001 • 91 citations

Increased Furin Activity Enhances the Malignant Phenotype of Human Head and Neck Cancer Cells

2003 • 91 citations

Transforming Growth Factor-β Promotes Survival of Mammary Carcinoma Cells through Induction of Antiapoptotic Transcription Factor DEC1

2007 • 89 citations

Stromal regulation of vessel stability by MMP14 and TGFβ

2010 • 87 citations

Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells

2002 • 87 citations

Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent

2001 • 86 citations

Clinical aspects of drug delivery to tumors

2002 • 80 citations

Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer

2004 • 72 citations

Delivery of Viral Vectors to Tumor Cells: Extracellular Transport, Systemic Distribution, and Strategies for Improvement

2006 • 69 citations

TGF-β Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma Models

2011 • 62 citations

Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent

2001 • 55 citations

Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma

2005 • 53 citations

Available Space and Extracellular Transport of Macromolecules: Effects of Pore Size and Connectedness

2001 • 49 citations

Characterization of TGF-β-regulated interleukin-8 expression in human prostate cancer cells

2006 • 37 citations

Proprotein Convertase 2

2012 • 29 citations

IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGFβ activity: potential role in tumor vessel stabilization

2004 • 25 citations